Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,271

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026

Most affected stateHawaii 200 recalls mention this state

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 20, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2074-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-5

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2071-2

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

rocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6010-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6008-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6007-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

ePHEDrine in 0.9% sodium chloride, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, CAPS Inc., Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6004-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 19, 2025Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility:
Published: October 11, 2023
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: December 19, 2023Historical recordClass II

Vive Organic

Product: 2 oz VIVE ORGANIC DETOX + IMMUNITY KIWI APPLE SUPERGREENS WE…
Reason: Undeclared allergen; coconut
Published: October 11, 2023
Distribution: Vive Organic did not sell directly to an…

View recall →

FDA Recall TerminatedTerminated: April 22, 2025Historical recordClass III

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

by RB Health (US) LLC

Reason: Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.
Published: October 4, 2023
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 3, 2024Historical recordClass III

Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.

by Tolmar, Inc.

Reason: Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Published: October 4, 2023
Distribution: Nationwide

View recall →

Data last updated: October 20, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.